NCT03672045View on ClinicalTrials.gov

Carbetocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With BMI ≥ 40kg/m2

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 19, 2018

Primary Completion Date

May 16, 2019

Study Completion Date

May 17, 2019

Conditions
Postpartum Hemorrhage
Interventions
DRUG

Carbetocin

carbetocin administered IV, over 1 minute following delivery of the fetal head

Trial Locations (1)

M5G1X5

Mount Sinai Hospital, Toronto

All Listed Sponsors
lead

Samuel Lunenfeld Research Institute, Mount Sinai Hospital

OTHER

NCT03672045 - Carbetocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With BMI ≥ 40kg/m2 | Biotech Hunter | Biotech Hunter